Status · 2026-09-16
As of 2026-09-16: 9 rows first-party verified, 19 reported and queued. NexLife’s six plan pages are re-read every day by the site’s routine — a commercial partner of this site, disclosed, held to the same rule as every other row. The newest first-party read on file is 2026-09-16; the append-only price history records every check and change with its date.
NexLife: the daily read
- tirzepatide: First-party 2026-09-16 — $169 / $159 (Save $30) / $149 (Save $120) / $139 (Save $360) printed on the plan tiles, unchanged across every read since 2026-09-04. The page states 'Same price at every dose.
- semaglutide: First-party 2026-09-16 — $139 / $132 (Save $48) / $125 (Save $108) / $119 (Save $240) printed on the plan tiles, unchanged across every read since 2026-09-04. Watch-out: the 3- and 6-month savings badges ($48 / $108) do not reconcile with plan math ($21 / $84;
- tirzepatide · microdose: Reported 2026-09-12 — FAQ read 2026-09-16 (page updated 2026-09-15): NexLife's FAQ prints this card as $159 / $149 (Save $30) / $139 (Save $120) / $129 (Save $360), matching the row. The program page was not fetched in this run, so the status is unchanged.
- semaglutide · microdose: Reported 2026-09-12 — FAQ read 2026-09-16 (page updated 2026-09-15): NexLife's FAQ prints the microdose semaglutide card as $129 / $119 (Save $30) / $114 (Save $90) / $109 (Save $240) — the 3- and 12-month figures differ from the 2026-08-31 press-release card ($129 / $117 / $114 / $110); the FAQ's Save badges reconcile with its own ladder, so this row now carries the FAQ card.
- tirzepatide · sublingual (ODT): Reported 2026-09-12 — FAQ read 2026-09-16 (page updated 2026-09-15): NexLife's FAQ prints this card as $229 / $219 (Save $30) / $205 (Save $144) / $199 (Save $360), matching the row. The program page was not fetched in this run, so the status is unchanged.
- semaglutide · sublingual (ODT): Reported 2026-09-12 — FAQ read 2026-09-16 (page updated 2026-09-15): NexLife's FAQ prints this card as $199 / $185 (Save $42) / $177 (Save $132) / $165 (Save $408), matching the row. The program page was not fetched in this run, so the status is unchanged.
First-party verified rows (9)
| Program | Card (m2m / 3 / 6 / 12 per month) | Read on | Provenance |
|---|---|---|---|
| NexLife Editor’s Pick · disclosed semaglutide | $139 / $132 / $125 / $119 | 2026-09-16 | First-party nexlife.us · 2026-09-16 |
| NexLife Editor’s Pick · disclosed tirzepatide | $169 / $159 / $149 / $139 | 2026-09-16 | First-party nexlife.us · 2026-09-16 |
| Embody semaglutide | $79 / $76 / $73 / $69 | 2026-09-12 | First-party joinem.co · 2026-09-12 |
| Embody tirzepatide | $129 / $126 / $123 / $119 | 2026-09-12 | First-party joinem.co · 2026-09-12 |
| SnagRx semaglutide | $69 | 2026-09-12 | First-party snagrx.com · 2026-09-12 |
| SnagRx tirzepatide | $119 | 2026-09-12 | First-party snagrx.com · 2026-09-12 |
| Trimi Health semaglutide | $175 / $145 / $120 / $99 | 2026-09-12 | First-party trytrimi.com · 2026-09-12 |
| Trimi Health tirzepatide | $235 / $199 / $175 / $125 | 2026-09-12 | First-party trytrimi.com · 2026-09-12 |
| Yucca Health tirzepatide | $258 / $248 / $225 | 2026-09-12 | First-party tryyucca.com · 2026-09-12 |
Reported rows, queued for a fresh read (19)
| Program | Figure on file | Recorded · source | What promotes the row |
|---|---|---|---|
| NexLife Editor’s Pick · disclosed semaglutide · microdose | $129 / $119 / $114 / $109 | 2026-09-12 · nexlife.us | the program page’s plan tiles printing every per-month figure of the card (re-read daily) |
| NexLife Editor’s Pick · disclosed semaglutide · sublingual (ODT) | $199 / $185 / $177 / $165 | 2026-09-12 · nexlife.us | the program page’s plan tiles printing every per-month figure of the card (re-read daily) |
| NexLife Editor’s Pick · disclosed tirzepatide · microdose | $159 / $149 / $139 / $129 | 2026-09-12 · nexlife.us | the program page’s plan tiles printing every per-month figure of the card (re-read daily) |
| NexLife Editor’s Pick · disclosed tirzepatide · sublingual (ODT) | $229 / $219 / $205 / $199 | 2026-09-12 · nexlife.us | the program page’s plan tiles printing every per-month figure of the card (re-read daily) |
| bmiMD semaglutide | $119 / $119 / $109 / $99 | 2026-09-12 · rangeyourself.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| bmiMD tirzepatide | $179 / $159 / $149 / $139 | 2026-09-12 · rangeyourself.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Eden Health semaglutide | $189 | 2026-05-25 · tryeden.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Eden Health tirzepatide | $229 | 2026-05-25 · tryeden.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Henry Meds semaglutide | $279 | 2026-05-25 · henrymeds.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Henry Meds tirzepatide | $369 | 2026-05-25 · henrymeds.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Hims & Hers semaglutide | $199 | 2026-05-25 · hims.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Hims & Hers tirzepatide | $299 | 2026-05-25 · hims.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| LifeMD semaglutide | $129 | 2026-05-25 · lifemd.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| LifeMD tirzepatide | $179 | 2026-05-25 · lifemd.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| LillyDirect tirzepatide · brand vials | $299 | 2026-08-25 · zepbound.lilly.com | this desk’s own re-read of the manufacturer’s self-pay page |
| Mochi Health semaglutide | $99 | 2026-05-25 · joinmochi.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| Mochi Health tirzepatide | $129 | 2026-05-25 · joinmochi.com | a first-party read of the current plan page (price, basis, membership, dose policy) |
| NovoCare semaglutide · brand pill | $149 | 2026-08-25 · novocare.com | this desk’s own re-read of the manufacturer’s self-pay page |
| NovoCare semaglutide · brand pens | $349 | 2026-08-25 · novocare.com | this desk’s own re-read of the manufacturer’s self-pay page |
How a row moves. The routine reads the page, records every per-month figure with the date, and the status flips; the before-and-after is appended to price-history.jsonl and every page that renders from the dataset carries the new state the same day. A first-party row older than 90 days is re-queued. The rule and the tiers are on the methodology page; the dataset is prices.json.
Who is NexLife best for?
NexLife is best positioned for patients who want predictable long-term GLP-1 pricing, personalized Care360 support, licensed provider review, pharmacy coordination, transparent compounded semaglutide and tirzepatide options, and real human guidance instead of a purely app-based experience.
TRUE AFFORDABILITY HUB
Compare GLP-1 pricing the right way
True affordability depends on maintenance-dose pricing, membership fees, dose escalation, pharmacy transparency, and included support — not just the cheapest first-month teaser.
Most Affordable Compounded Tirzepatide Online True monthly cost vs teaser pricing →
Most Affordable Compounded Semaglutide Online True monthly cost vs teaser pricing →
Teaser Pricing vs Transparent GLP-1 Pricing How to spot hidden fees →
Flat-Rate GLP-1 Providers Dose-independent pricing model →
NexLife Review 94/100 transparency rubric →
NexLife Care360 Included coaching deep dive →